Contracts › 75N94025F00001
75N94025F00001: Nichd: R&D: Coordination, Monitoring, Follow-Up, Evaluation, and Completion of a Clinical Trial of Nestorone Testosterone Gel for Male Contraception: Non-Severable
Awarded to Health Decisions, Inc. by National Institutes of Health (NIH).
$1.2Mobligated
$1.2Mpotential value
31 October 2027current end date
See modifications, all subcontractors and funding in FedSift →
| Contract | 75N94025F00001 |
|---|---|
| Vehicle | 75N94019D00004 |
| Awardee | Health Decisions, Inc. |
| Awarding agency | National Institutes of Health (NIH) |
| Awarding office | NATIONAL INSTITUTES OF HEALTH NICHD |
| NAICS | 541715 Research and Development in the Physical, Engineering, and Life Sciences (Except Nanotechnology and Biotechnology) |
| PSC | AN12 Health R&D Services; Health Care Services; Applied Research |
| Place of performance | NC |
| Period of performance | 01 May 2025 to 31 October 2027 |
| Potential end | 31 October 2027 |
| Estimated recompete solicitation | ~Q2 2027 (estimate, ~6 months before expiry) |
Source: USASpending.gov (FPDS), public federal procurement data, as the agency reported it. Our record updated 03 October 2026. The solicitation date is an estimate from the end date, not a posted date.
Other expiring 541715 contracts · All expiring contracts · USASpending record